Literature DB >> 11696727

Organ sparing surgery for malignant germ cell tumor of the testis.

A Heidenreich1, L Weissbach, W Höltl, P Albers, S Kliesch, K U Köhrmann, K P DIeckmann.   

Abstract

PURPOSE: We evaluate the indication, technique and long-term outcome of organ preserving tumor resection rather than standard orchiectomy in 73 patients with bilateral testicular germ cell tumors or tumors of a solitary testicle.
MATERIALS AND METHODS: Tumor resection was performed in 73 patients with 52 and 17 metachronous and synchronous bilateral testicular germ cell tumors, respectively, and 4 testicular germ cell tumors of a solitary testicle. Histology of the enucleated germ cell tumor revealed seminoma in 42 (57.5%) patients, embryonal carcinoma in 14 (19.2%), mature teratoma in 11 (15.1%), and mixed and combined germ cell tumors in 6 (8.2%). Mean tumor diameter was 15 mm. (range 5 to 30). Associated testicular intraepithelial neoplasia was diagnosed in 82% of patients who underwent local radiation with 18 Gy.
RESULTS: After a median followup of 91 months (range 3 to 191) 72 (98.6%) patients had no evidence of disease and 1 died of systemic tumor progression. No local relapse occurred in 46 patients with associated testicular intraepithelial neoplasia treated with local radiation. However, local recurrence did develop in 4 patients after 3, 6, 12 and 165 months without radiation but all survived after undergoing inguinal orchiectomy. Testosterone levels were normal in 62 (84.9%) patients, hypogonadism developed in 7 (9.6%) and preoperative levels remained low in 4 (5.5%). Of the 10 patients who postponed local radiation for paternity reasons 5 had successfully fathered a child after organ sparing surgery.
CONCLUSIONS: After a long-term followup of greater than 7 years organ sparing surgery represents a viable therapeutic approach to bilateral testicular germ cell tumor with an excellent postoperative outcome. Tumor enucleation might be considered a standard approach if the guidelines are respected, including cold ischemia, organ confined tumor less than 20 mm., multiple biopsies of the tumor bed, adjuvant local irradiation postoperatively to avoid local recurrence, close followup and high compliance.

Entities:  

Mesh:

Year:  2001        PMID: 11696727     DOI: 10.1016/s0022-5347(05)65526-7

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  56 in total

1.  Testicular Cancer on the Web-an Appropriate Source of Patient Information in Concordance with the European Association of Urology Guidelines?

Authors:  Pia Paffenholz; Johannes Salem; Hendrik Borgmann; Tim Nestler; David Pfister; Christian Ruf; Igor Tsaur; Axel Haferkamp; Axel Heidenreich
Journal:  J Cancer Educ       Date:  2018-12       Impact factor: 2.037

Review 2.  [What is new in 2011 regarding testicular cancer].

Authors:  S Krege
Journal:  Urologe A       Date:  2011-09       Impact factor: 0.639

3.  [Testicular tumor--yesterday--today--tomorrow].

Authors:  S Krege; C Wittekind; R Souchon; F Honecker; C Bokemeyer; P Albers; J Gschwend; H Rübben
Journal:  Urologe A       Date:  2006-09       Impact factor: 0.639

Review 4.  [Organ-sparing surgery for testicular tumors].

Authors:  L Weissbach; C Schaefer
Journal:  Urologe A       Date:  2008-07       Impact factor: 0.639

5.  A small mass in a single testis after orchiectomy for testis cancer.

Authors:  Mark Soloway
Journal:  Curr Urol Rep       Date:  2008-01       Impact factor: 3.092

Review 6.  [Importance of pathology for therapy planning of testicular germ cell tumors].

Authors:  A Heidenreich; R Knüchel-Clarke; D Pfister
Journal:  Pathologe       Date:  2014-05       Impact factor: 1.011

7.  Organ-sparing surgery is the treatment of choice in benign testicular tumors.

Authors:  Nicolai Leonhartsberger; Renate Pichler; Brigitte Stoehr; Wolfgang Horninger; Hannes Steiner
Journal:  World J Urol       Date:  2013-10-04       Impact factor: 4.226

Review 8.  [Aftercare in testicular cancer is worthwhile. Recurrences are curable].

Authors:  T S Pottek; K-P Dieckmann
Journal:  Urologe A       Date:  2005-09       Impact factor: 0.639

9.  MicroRNA expression profiles of seminoma from paraffin-embedded formalin-fixed tissue.

Authors:  Z Bing; S R Master; J W Tobias; D A Baldwin; X W Xu; J E Tomaszewski
Journal:  Virchows Arch       Date:  2012-10-14       Impact factor: 4.064

10.  Efficacy of routine follow-up after first-line treatment for testicular cancer.

Authors:  J R Spermon; J A Witjes; L A L M Kiemeney
Journal:  World J Urol       Date:  2004-09-21       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.